Literature DB >> 9551418

Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain.

R A Mactier1, T S Sprosen, R Gokal, P F Williams, M Lindbergh, R B Naik, U Wrege, K C Gröntoft, R Larsson, J Berglund, A P Tranaeus, D Faict.   

Abstract

A randomized, double-blind, cross-over study was undertaken to determine the effects of novel bicarbonate (38 mM) and bicarbonate (25 mM)/lactate (15 mM) containing peritoneal dialysis (PD) solutions on infusion pain in patients who experienced inflow pain with conventional lactate (40 mM) solution. Pain was assessed using a verbal rating scale and the validated McGill Pain Questionnaire (MPQ). Eighteen patients were recruited to the study. Both novel solutions resulted in highly statistically significant reductions in inflow pain compared to the control lactate solution, as assessed with both the verbal rating scale and the MPQ. For all pain variables assessed, the bicarbonate/lactate solution was more effective than the bicarbonate solution in alleviating pain. In conclusion, both solutions reduced the infusion pain experienced with control solution, but the bicarbonate/lactate solution appears to be the most effective. In contrast to the most widespread current treatment, which is the manual injection of sodium bicarbonate, the bicarbonate/lactate solution does not have the associated increased risk of peritonitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551418     DOI: 10.1111/j.1523-1755.1998.00849.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

Review 1.  New peritoneal dialysis fluids: practical use for children.

Authors:  Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2003-11       Impact factor: 3.714

2.  Trials (and tribulations) of biocompatible peritoneal dialysis fluids.

Authors:  David W Johnson; Yeoungjee Cho; Fiona G Brown
Journal:  Perit Dial Int       Date:  2012 May-Jun       Impact factor: 1.756

Review 3.  Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

Authors:  Murali Krishnan; Paul Tam; George Wu; Andrzej Breborowicz; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 4.  Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions.

Authors:  Ahad Qayyum; Elizabeth Ley Oei; Klara Paudel; Stanley L Fan
Journal:  World J Nephrol       Date:  2015-02-06

5.  Balance about balANZ.

Authors:  Peter G Blake
Journal:  Perit Dial Int       Date:  2012 Sep-Oct       Impact factor: 1.756

6.  Hyperbranched polyglycerol: a future alternative to polyglucose in peritoneal dialysis fluids?

Authors:  Bengt Rippe
Journal:  Perit Dial Int       Date:  2013 Jan-Feb       Impact factor: 1.756

7.  Drain pain, overfill, and how they are connected.

Authors:  Peter Blake
Journal:  Perit Dial Int       Date:  2014-06       Impact factor: 1.756

8.  Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group.

Authors:  Claus Peter Schmitt; Sevcan A Bakkaloglu; Günter Klaus; Cornelis Schröder; Michel Fischbach
Journal:  Pediatr Nephrol       Date:  2011-03-31       Impact factor: 3.714

9.  Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.

Authors:  Bart Dioos; Goedele Paternot; Rose-Marie Jenvert; Annick Duponchelle; Mark R Marshall; Migaku Nakajima; Edward Ramirez Ganoza; James A Sloand; Anders P Wieslander
Journal:  Clin Exp Nephrol       Date:  2018-06-20       Impact factor: 2.801

Review 10.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.